Correlation Between Biostage and Guided Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biostage and Guided Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biostage and Guided Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biostage and Guided Therapeutics, you can compare the effects of market volatilities on Biostage and Guided Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biostage with a short position of Guided Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biostage and Guided Therapeutics.

Diversification Opportunities for Biostage and Guided Therapeutics

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Biostage and Guided is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Biostage and Guided Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guided Therapeutics and Biostage is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biostage are associated (or correlated) with Guided Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guided Therapeutics has no effect on the direction of Biostage i.e., Biostage and Guided Therapeutics go up and down completely randomly.

Pair Corralation between Biostage and Guided Therapeutics

Given the investment horizon of 90 days Biostage is expected to under-perform the Guided Therapeutics. But the otc stock apears to be less risky and, when comparing its historical volatility, Biostage is 3.96 times less risky than Guided Therapeutics. The otc stock trades about -0.06 of its potential returns per unit of risk. The Guided Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  16.00  in Guided Therapeutics on September 2, 2024 and sell it today you would earn a total of  3.00  from holding Guided Therapeutics or generate 18.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy7.8%
ValuesDaily Returns

Biostage  vs.  Guided Therapeutics

 Performance 
       Timeline  
Biostage 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biostage has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Biostage is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Guided Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Guided Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent technical indicators, Guided Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Biostage and Guided Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biostage and Guided Therapeutics

The main advantage of trading using opposite Biostage and Guided Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biostage position performs unexpectedly, Guided Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guided Therapeutics will offset losses from the drop in Guided Therapeutics' long position.
The idea behind Biostage and Guided Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation